LSIPR 50 2018: Alisa Harbin
Alisa Harbin was selected in the LSIPR 50 2018 publication for her influence on the life sciences industry. She featured in the legal section, as LSIPR reports.
- LSIPR 50 2018: Robert DeBerardine 16-08-2018
- LSIPR 50 2018: Padmanabh Bhatt 15-08-2018
- LSIPR 50 2018: Roy Waldron 14-08-2018
- Combination SPCs: shaken and stirred 14-08-2018
- LSIPR 50 2018: Elaine Waller 13-08-2018
Latest news
FDA grants Teva approval for first EpiPen generic
17-08-2018
The US Food and Drug Administration yesterday granted Teva approval for the first generic version of EpiPen, an autoinjector pen used for the emergency treatment of allergic reactions.
Purdue and Amneal OxyContin clash ends
15-08-2018
